Core IM | Internal Medicine Podcast cover image

#189 Bisphosphonates and Fracture Prevention Trial: Beyond Journal Club with NEJM Group

Core IM | Internal Medicine Podcast

00:00

Did infrequent zoledronate reduce fractures in this low-risk group?

Results showed both one- and two-dose zoledronate arms reduced vertebral and major osteoporotic fractures with 30–40% relative reductions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app